Fetal Exposure to Common Epilepsy Drugs May Harm Kids'
THURSDAY, June 30 (HealthDay News) -- The U.S. Food and Drug
Administration on Thursday advised doctors to warn women of
childbearing age that fetal exposure to certain drugs used to
control seizures or migraines appears to diminish intellectual
abilities in offspring.
The drugs include so-called "valproate products" -- medications
such as valproate sodium (Depacon), divalproex sodium (Depakote,
Depakote CP, Depakote ER), valproic acid (Depakene, Stavzor), and
their equivalent generic formulations, the FDA said in a
Children born to women who take these medications during their
pregnancy "have an increased risk of lower cognitive test scores
than children exposed to other anti-seizure medications during
pregnancy," the FDA said.
The agency said it based its conclusions on epidemiological
studies that showed that fetal exposures to the drugs tended to
correlate with lower scores on IQ and other cognitive tests.
Valproate drugs are FDA-approved for use against epilepsy,
migraine and bipolar disorder, although the agency notes that they
are also used "off-label" for other conditions, mainly other
The drugs have also long been linked to an increased risk of
birth defects known as neural tube defects, the agency noted.
The FDA advises that doctors counsel women of childbearing age
of the risks to offspring associated with valproate products, and
"weigh the benefits and risks of valproate when prescribing this
drug to women of childbearing age, particularly when treating a
condition not usually associated with permanent injury or death.
Alternative medications that have a lower risk of adverse birth
outcomes should be considered."
In late 2010, a Swedish study of over 1,200 teenage children
born to women with epilepsy found that those born to women who took
two or more epilepsy drugs while pregnant fared worse in school
than peers with no prenatal exposure to those medications.
The findings, published in
Epilepsia, echoed earlier research that linked prenatal exposure to epilepsy drugs, particularly valproic acid medications (such as Depakene and Depakote), to negative effects on a child's ability to process information, solve problems and make decisions.
"Our results suggest that exposure to several anti-epileptic drugs in utero may have a negative effect on a child's neurodevelopment," study author Dr. Lisa Forsberg of Karolinska University Hospital told HealthDay at the time.
Forsberg recommended that women with epilepsy plan their
pregnancies. "That way, they and their doctors can come up with
individual treatment plans that make the pregnancy safe for both
mother and child," she said.
To learn more about women and epilepsy, visit the
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.